Produkty 14507-49-4

CAS 14507-49-4 występuje w naszej ofercie pod nazwami: Levonorgestrel EP Impurity Q, 13-Ethyl-3-methoxy-gona-2,5(10)-dien-17beta-ol, 13-Ethyl-3-methoxygona-2,5(10)-dien-17beta-ol. Oferty producentów: Chemat Brand, TRC. Dostępne opakowania: on request, 1g, 25mg.

Levonorgestrel EP Impurity Q
Chemat Brand
  • opakowanie: on request
  • Warianty: 1
Zobacz produkt
13-Ethyl-3-methoxy-gona-2,5(10)-dien-17beta-ol
TRC
  • opakowanie: 1g
  • Warianty: 1
Zobacz produkt
13-Ethyl-3-methoxygona-2,5(10)-dien-17beta-ol
TRC
  • opakowanie: 25mg
  • Warianty: 1
Zobacz produkt

13-ethyl-3-methoxy-1,4,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-16-ol (CAS 14507-49-4) to związek chemiczny o wzorze sumarycznym C20H30O2 i masie molowej 302.5 g/mol. Nazwa systematyczna IUPAC: 13-ethyl-3-methoxy-1,4,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-16-ol. InChIKey: BIUKNRSGOGLWJB-UHFFFAOYSA-N.

Dane identyfikacyjne
Wzór sumarycznyC20H30O2
Masa molowa302.5 g/mol
Nazwa IUPAC13-ethyl-3-methoxy-1,4,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-16-ol
InChIKeyBIUKNRSGOGLWJB-UHFFFAOYSA-N
SMILESCCC12CCC3C(C1CC(C2)O)CCC4=C3CC=C(C4)OC

Dane obliczone przez PubChem (NCBI)

Synonimy: 13-Ethyl-3-methoxygona-2,5(10)-dien-17beta-ol, LEVONORGESTREL IMPURITY Q (EP IMPURITY), LEVONORGESTREL IMPURITY Q [EP IMPURITY]
Izomery (ten sam wzór sumaryczny)
(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoic acid C20H30O2
(3R,5R,8R,9R,10S,13S,14S,17R)-17-ethynyl-13-methyl-2,3,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol C20H30O2
(1S,4S,5R,9S,10R,13R)-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.01,10.04,9]hexadecane-5-carboxylic acid C20H30O2
(2E,4E,6E,8E)-3,7-dimethyl-9-(2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl)nona-2,4,6,8-tetraen-1-ol C20H30O2
(1R,4aR,4bR,10aR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboxylic acid C20H30O2
(8R,9S,10R,13S,14S,17S)-17-ethyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one C20H30O2
(8R,9S,13S,14S,17S)-13-ethyl-3-methoxy-1,4,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-ol C20H30O2
(3S,5S,8R,9R,10S,13S,14S,17R)-17-ethynyl-13-methyl-2,3,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol C20H30O2
(3R,5S,8R,9R,10S,13S,14S,17R)-17-ethynyl-13-methyl-2,3,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol C20H30O2
4-[(1E,3E,5E,7E)-9-hydroxy-3,7-dimethylnona-1,3,5,7-tetraenyl]-3,5,5-trimethylcyclohex-3-en-1-ol C20H30O2
(5Z,8Z,11Z,14Z,17Z)-19,19,20,20,20-pentadeuterioicosa-5,8,11,14,17-pentaenoic acid C20H30O2
(7R,8R,9S,13S,14S,17S)-3-methoxy-7,13-dimethyl-1,4,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-ol C20H30O2